OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Evaluation of PD-L1, tumor-infiltrating lymphocytes, and CD8+ and FOXP3+ immune cells in HER2-positive breast cancer treated with neoadjuvant therapies
Jing Zhao, Jane Meisel, Yi Guo, et al.
Breast Cancer Research and Treatment (2020) Vol. 183, Iss. 3, pp. 599-606
Closed Access | Times Cited: 14
Jing Zhao, Jane Meisel, Yi Guo, et al.
Breast Cancer Research and Treatment (2020) Vol. 183, Iss. 3, pp. 599-606
Closed Access | Times Cited: 14
Showing 14 citing articles:
Oncogenes and tumor suppressor genes: functions and roles in cancers
Tikam Chand Dakal, Bhanupriya Dhabhai, Anuja Pant, et al.
MedComm (2024) Vol. 5, Iss. 6
Open Access | Times Cited: 20
Tikam Chand Dakal, Bhanupriya Dhabhai, Anuja Pant, et al.
MedComm (2024) Vol. 5, Iss. 6
Open Access | Times Cited: 20
High tumor infiltrating lymphocytes are significantly associated with pathological complete response in triple negative breast cancer treated with neoadjuvant KEYNOTE-522 chemoimmunotherapy
S.J. Wood, Yuan Gao, Ji‐Hoon Lee, et al.
Breast Cancer Research and Treatment (2024) Vol. 205, Iss. 1, pp. 193-199
Closed Access | Times Cited: 11
S.J. Wood, Yuan Gao, Ji‐Hoon Lee, et al.
Breast Cancer Research and Treatment (2024) Vol. 205, Iss. 1, pp. 193-199
Closed Access | Times Cited: 11
Deep learning in digital pathology for personalized treatment plans of cancer patients
Zhuoyu Wen, Shidan Wang, Donghan M. Yang, et al.
Seminars in Diagnostic Pathology (2023) Vol. 40, Iss. 2, pp. 109-119
Open Access | Times Cited: 18
Zhuoyu Wen, Shidan Wang, Donghan M. Yang, et al.
Seminars in Diagnostic Pathology (2023) Vol. 40, Iss. 2, pp. 109-119
Open Access | Times Cited: 18
Clinical trial data and emerging strategies: HER2-positive breast cancer
Sònia Pernas, Sara M. Tolaney
Breast Cancer Research and Treatment (2022) Vol. 193, Iss. 2, pp. 281-291
Closed Access | Times Cited: 20
Sònia Pernas, Sara M. Tolaney
Breast Cancer Research and Treatment (2022) Vol. 193, Iss. 2, pp. 281-291
Closed Access | Times Cited: 20
Molecular Classification of Triple Negative Breast Cancer and the Emergence of Targeted Therapies
Elizabeth Sakach, Ruth O’Regan, Jane Meisel, et al.
Clinical Breast Cancer (2021) Vol. 21, Iss. 6, pp. 509-520
Closed Access | Times Cited: 23
Elizabeth Sakach, Ruth O’Regan, Jane Meisel, et al.
Clinical Breast Cancer (2021) Vol. 21, Iss. 6, pp. 509-520
Closed Access | Times Cited: 23
Deep Learning-Based Pathology Image Analysis Enhances Magee Feature Correlation With Oncotype DX Breast Recurrence Score
Hongxiao Li, Jigang Wang, Zaibo Li, et al.
Frontiers in Medicine (2022) Vol. 9
Open Access | Times Cited: 13
Hongxiao Li, Jigang Wang, Zaibo Li, et al.
Frontiers in Medicine (2022) Vol. 9
Open Access | Times Cited: 13
Relationship Between Programmed Death Ligand 1 Expression and Other Clinicopathological Features in a Large Cohort of Gastric Cancer Patients
Xinhua Chen, Huimin Zhang, Minghao Wang, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 11
Xinhua Chen, Huimin Zhang, Minghao Wang, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 11
GPR81-mediated reprogramming of glucose metabolism contributes to the immune landscape in breast cancer
Xiaofeng Li, Yiwen Chen, Ting Wang, et al.
Discover Oncology (2023) Vol. 14, Iss. 1
Open Access | Times Cited: 5
Xiaofeng Li, Yiwen Chen, Ting Wang, et al.
Discover Oncology (2023) Vol. 14, Iss. 1
Open Access | Times Cited: 5
Tumor Microenvironment Characterization in Breast Cancer Identifies Prognostic and Neoadjuvant Chemotherapy Relevant Signatures
Fei Ji, Jiao-Mei Yuan, Hongfei Gao, et al.
Frontiers in Molecular Biosciences (2021) Vol. 8
Open Access | Times Cited: 8
Fei Ji, Jiao-Mei Yuan, Hongfei Gao, et al.
Frontiers in Molecular Biosciences (2021) Vol. 8
Open Access | Times Cited: 8
The association of PD-L1 expression and CD8-positive T cell infiltration rate with the pathological complete response after neoadjuvant treatment in HER2-positive breast cancer
Kenan Çetin, Şermin Çoban Kökten, B. Sarikamış, et al.
Breast Cancer Research and Treatment (2024) Vol. 205, Iss. 1, pp. 17-27
Open Access
Kenan Çetin, Şermin Çoban Kökten, B. Sarikamış, et al.
Breast Cancer Research and Treatment (2024) Vol. 205, Iss. 1, pp. 17-27
Open Access
Prognostic Value of Tumor Infiltrating Lymphocytes in Locally Advanced HER2 Enriched Breast Cancer
Mostafa Saber, Heba El Zawahry, Amany Hilal, et al.
Asian Pacific Journal of Cancer Prevention (2022) Vol. 23, Iss. 2, pp. 553-560
Open Access | Times Cited: 2
Mostafa Saber, Heba El Zawahry, Amany Hilal, et al.
Asian Pacific Journal of Cancer Prevention (2022) Vol. 23, Iss. 2, pp. 553-560
Open Access | Times Cited: 2
Assessment of the relationships between Ki67 expression and neoadjuvant treatment response and prognosis in breast cancer using two types of response evaluation systems
Yurdanur Süllü, Güzin Demirağ, Bekir Kuru, et al.
Research Square (Research Square) (2022)
Open Access
Yurdanur Süllü, Güzin Demirağ, Bekir Kuru, et al.
Research Square (Research Square) (2022)
Open Access
HUBUNGAN TUMOR INFILTRATING LYMPHOCYTE CD8+ DENGAN USIA, GRADING, EKSPRESI HER2 DAN Ki67 PADA INVASIVE BREAST CARCINOMA OF NO SPECIAL TYPE DI RSUD dr. SAIFUL ANWAR MALANG
Rita Ervina, Eviana Norahmawati, Arif Satria Hardika, et al.
majalah kesehatan (2022) Vol. 9, Iss. 2, pp. 68-77
Open Access
Rita Ervina, Eviana Norahmawati, Arif Satria Hardika, et al.
majalah kesehatan (2022) Vol. 9, Iss. 2, pp. 68-77
Open Access
Assessment of the relationships between Ki67 expression and neoadjuvant treatment response and prognosis in breast cancer using two types of response evaluation systems
Yurdanur Süllü, Güzin Demirağ, Bekir Kuru, et al.
Research Square (Research Square) (2022)
Open Access
Yurdanur Süllü, Güzin Demirağ, Bekir Kuru, et al.
Research Square (Research Square) (2022)
Open Access
